Literature DB >> 26917587

TTFields: where does all the skepticism come from?

Wolfgang Wick1.   

Abstract

Mesh:

Year:  2016        PMID: 26917587      PMCID: PMC4767251          DOI: 10.1093/neuonc/now012

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  13 in total

1.  Adjuvant chemotherapy for adenocarcinoma of the lung--is the standard of care ready for change?

Authors:  Robert B Diasio
Journal:  N Engl J Med       Date:  2004-04-22       Impact factor: 91.245

2.  A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.

Authors:  Manfred Westphal; Dana C Hilt; Enoch Bortey; Patrick Delavault; Robert Olivares; Peter C Warnke; Ian R Whittle; Juha Jääskeläinen; Zvi Ram
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

3.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

4.  NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.

Authors:  Roger Stupp; Eric T Wong; Andrew A Kanner; David Steinberg; Herbert Engelhard; Volkmar Heidecke; Eilon D Kirson; Sophie Taillibert; Frank Liebermann; Vladimir Dbalý; Zvi Ram; J Lee Villano; Nikolai Rainov; Uri Weinberg; David Schiff; Lara Kunschner; Jeffrey Raizer; Jerome Honnorat; Andrew Sloan; Mark Malkin; Joseph C Landolfi; Franz Payer; Maximilian Mehdorn; Robert J Weil; Susan C Pannullo; Manfred Westphal; Martin Smrcka; Lawrence Chin; Herwig Kostron; Silvia Hofer; Jeffrey Bruce; Rees Cosgrove; Nina Paleologous; Yoram Palti; Philip H Gutin
Journal:  Eur J Cancer       Date:  2012-05-18       Impact factor: 9.162

5.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

6.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

7.  Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.

Authors:  Mark R Gilbert; Meihua Wang; Kenneth D Aldape; Roger Stupp; Monika E Hegi; Kurt A Jaeckle; Terri S Armstrong; Jeffrey S Wefel; Minhee Won; Deborah T Blumenthal; Anita Mahajan; Christopher J Schultz; Sara Erridge; Brigitta Baumert; Kristen I Hopkins; Tzahala Tzuk-Shina; Paul D Brown; Arnab Chakravarti; Walter J Curran; Minesh P Mehta
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

8.  Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial.

Authors:  Roger Stupp; Monika E Hegi; Thierry Gorlia; Sara C Erridge; James Perry; Yong-Kil Hong; Kenneth D Aldape; Benoit Lhermitte; Torsten Pietsch; Danica Grujicic; Joachim Peter Steinbach; Wolfgang Wick; Rafał Tarnawski; Do-Hyun Nam; Peter Hau; Astrid Weyerbrock; Martin J B Taphoorn; Chiung-Chyi Shen; Nalini Rao; László Thurzo; Ulrich Herrlinger; Tejpal Gupta; Rolf-Dieter Kortmann; Krystyna Adamska; Catherine McBain; Alba A Brandes; Joerg Christian Tonn; Oliver Schnell; Thomas Wiegel; Chae-Yong Kim; Louis Burt Nabors; David A Reardon; Martin J van den Bent; Christine Hicking; Andriy Markivskyy; Martin Picard; Michael Weller
Journal:  Lancet Oncol       Date:  2014-08-19       Impact factor: 41.316

Review 9.  MGMT testing--the challenges for biomarker-based glioma treatment.

Authors:  Wolfgang Wick; Michael Weller; Martin van den Bent; Marc Sanson; Markus Weiler; Andreas von Deimling; Christoph Plass; Monika Hegi; Michael Platten; Guido Reifenberger
Journal:  Nat Rev Neurol       Date:  2014-06-10       Impact factor: 42.937

10.  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

Authors:  Roger Stupp; Sophie Taillibert; Andrew A Kanner; Santosh Kesari; David M Steinberg; Steven A Toms; Lynne P Taylor; Frank Lieberman; Antonio Silvani; Karen L Fink; Gene H Barnett; Jay-Jiguang Zhu; John W Henson; Herbert H Engelhard; Thomas C Chen; David D Tran; Jan Sroubek; Nam D Tran; Andreas F Hottinger; Joseph Landolfi; Rajiv Desai; Manuela Caroli; Yvonne Kew; Jerome Honnorat; Ahmed Idbaih; Eilon D Kirson; Uri Weinberg; Yoram Palti; Monika E Hegi; Zvi Ram
Journal:  JAMA       Date:  2015-12-15       Impact factor: 56.272

View more
  22 in total

1.  A systematic review of tumor treating fields therapy for high-grade gliomas.

Authors:  Pavan P Shah; Taija White; Adham M Khalafallah; Carlos G Romo; Carrie Price; Debraj Mukherjee
Journal:  J Neurooncol       Date:  2020-06-23       Impact factor: 4.130

Review 2.  Advances in the molecular genetics of gliomas - implications for classification and therapy.

Authors:  Guido Reifenberger; Hans-Georg Wirsching; Christiane B Knobbe-Thomsen; Michael Weller
Journal:  Nat Rev Clin Oncol       Date:  2016-12-29       Impact factor: 66.675

3.  Impact of the Patient Protection and Affordable Care Act on 1-year survival in glioblastoma patients.

Authors:  Nuriel Moghavem; Debora L Oh; Eduardo J Santiago-Rodríguez; William J Tate; Scarlett Lin Gomez; Reena Thomas
Journal:  Neurooncol Adv       Date:  2020-06-19

Review 4.  Glioblastoma in elderly patients: solid conclusions built on shifting sand?

Authors:  Antje Wick; Tobias Kessler; Andrew E H Elia; Frank Winkler; Tracy T Batchelor; Michael Platten; Wolfgang Wick
Journal:  Neuro Oncol       Date:  2018-01-22       Impact factor: 12.300

Review 5.  Tumor-Treating Fields for the treatment of glioblastoma: a systematic review and meta-analysis.

Authors:  Ohad Regev; Vladimir Merkin; Deborah T Blumenthal; Israel Melamed; Tehila Kaisman-Elbaz
Journal:  Neurooncol Pract       Date:  2021-04-20

Review 6.  Tumor-Treating Fields Therapy for Pediatric Brain Tumors.

Authors:  Atsushi Makimoto; Ryo Nishikawa; Keita Terashima; Jun Kurihara; Hiroyuki Fujisaki; Satoshi Ihara; Yoshihiko Morikawa; Yuki Yuza
Journal:  Neurol Int       Date:  2021-04-08

7.  Biological activity of tumor-treating fields in preclinical glioma models.

Authors:  Manuela Silginer; Michael Weller; Roger Stupp; Patrick Roth
Journal:  Cell Death Dis       Date:  2017-04-20       Impact factor: 8.469

8.  Real-World Evidence in Glioblastoma: Stupp's Regimen After a Decade.

Authors:  Radek Lakomy; Tomas Kazda; Iveta Selingerova; Alexandr Poprach; Petr Pospisil; Renata Belanova; Pavel Fadrus; Vaclav Vybihal; Martin Smrcka; Radim Jancalek; Ludmila Hynkova; Katarina Muckova; Michal Hendrych; Jiri Sana; Ondrej Slaby; Pavel Slampa
Journal:  Front Oncol       Date:  2020-07-03       Impact factor: 6.244

9.  Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.

Authors:  Martin J B Taphoorn; Linda Dirven; Andrew A Kanner; Gitit Lavy-Shahaf; Uri Weinberg; Sophie Taillibert; Steven A Toms; Jerome Honnorat; Thomas C Chen; Jan Sroubek; Carlos David; Ahmed Idbaih; Jacob C Easaw; Chae-Yong Kim; Jordi Bruna; Andreas F Hottinger; Yvonne Kew; Patrick Roth; Rajiv Desai; John L Villano; Eilon D Kirson; Zvi Ram; Roger Stupp
Journal:  JAMA Oncol       Date:  2018-04-01       Impact factor: 31.777

10.  World Cancer Day 2021 - Perspectives in Pediatric and Adult Neuro-Oncology.

Authors:  Erik P Sulman; David D Eisenstat
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.